Back
Chenghe Acquisition II Vs. Novo Nordisk AS Industry Stock Comparison
Sell
9
CHEB
Chenghe Acquisition II
Last Price:
$10.10
Seasonality Move:
--
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Sell
9
Chenghe Acquisition II (CHEB)
is a Sell
Is Chenghe Acquisition II a Buy, Sell or Hold?
-
The current Chenghe Acquisition II [CHEB] share price is $10.06. The Score for CHEB is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
CHEB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CHEB Stock Price Chart
What is Chenghe Acquisition II's stock price today?
-
The Chenghe Acquisition II share price today is $10.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHEB is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
CHEB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.88 | Buy |
| Chaikin Money Flow: | -19065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.05 - 10.07) | Sell |
| Bollinger Bands (100): | (9.99 - 10.05) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.51 | Sell |
| Relative Strength Index (14 RSI): | 24.55 | Sell |
| Chaikin Money Flow: | 64911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.57 - 111.43) | Sell |
| Bollinger Bands (100): | (107.18 - 131.16) | Sell |
CHEB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.07 | Sell |
| 20-day SMA: | 10.06 | Buy |
| 50-day SMA: | 10.04 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 10.06 | Sell |
| 20-day EMA: | 10.06 | Buy |
| 50-day EMA: | 10.04 | Buy |
| 200-day EMA: | 1.49 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.03 | Sell |
| 20-day SMA: | 106.85 | Sell |
| 50-day SMA: | 109.33 | Sell |
| 200-day SMA: | 126.14 | Sell |
| 8-day EMA: | 102.09 | Sell |
| 20-day EMA: | 105.65 | Sell |
| 50-day EMA: | 110.06 | Sell |
| 200-day EMA: | 118.01 | Sell |
Chenghe Acquisition II Earnings Growth & CHEB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Chenghe Acquisition II Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||